Can you benefit from the new ‘GAME-CHANGING’ FDA approved drug for weight loss?

A new weight-loss drug that produced jaw-dropping clinical trial results in early 2021 may be the ammunition needed to get you to your weight loss goal. Semaglutide, an injectable drug already approved by the Food and Drug Administration as a treatment for Type 2 diabetes, produced moderate weight loss at its dose of 1 milligram weekly. Participants lost an average of 37 pounds through the combination of semaglutide and diet change.

“Semaglutide is part of a class of medications called GLP-1 receptor agonists, or glucagon-like peptide-1 receptor agonists. It increases insulin secretion, which is good for diabetes. But at higher doses, it acts on centers in the brain and suppresses appetite. It is important to use this medication in conjunction with lifestyle intervention. What this medicine does is help patients adhere to a reduced-calorie diet. With obesity, you always need lifestyle changes plus medicine.”

Should be used with a reduced calorie meal plan and increased physical activities. Semaglutide should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines. “You always have to consider nausea, vomiting, diarrhea, constipation” as potential side effects, he said. “But these are very manageable. Those tend to come on early in the course of treatment and get better over time. Only infrequently are they serious enough that patients have to stop taking the drug

4-month supply when dosed according to above recommendations.

Semaglutide can be cycled with Elite Thermogenic Formula if needed to maintain weight. Must cycle off for 3 months. If therapy restarted, start back at Round 1 dosing.

Please select payment plan option and add to cart.